This inventor holds 2 USPTO granted patents. Top assignees: Hadasit Medical Research Services and Development Company, Hadasit Medical Research Services and Development Ltd.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 31 
1 out of 182 Years Active: 2002-2004
Title: Eliezer A Rachmilewitz: Innovator in Medical Research
Introduction
Eliezer A Rachmilewitz is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medical research, particularly in the development of biologically active serum-derived compositions. With a total of 2 patents, his work has the potential to impact therapeutic practices significantly.
Latest Patents
One of Rachmilewitz's latest patents is titled "Serum-derived factor inducing cell differentiation and medical uses thereof." This invention relates to a serum-derived composition that is biologically active, has a low molecular weight, and is electrically charged at acidic pH. The molecular weight of this serum-derived factor (SDF) is determined to be 316 Da through electron spray mass spectrometry. The SDF or its complex with ceruloplasmin (CP) exhibits several therapeutic properties. It can induce terminal cell differentiation of leukemic cells, which may lead to a loss of their ability to proliferate and self-renew. Additionally, the SDF or its complex with CP can stimulate the proliferation of early, normal progenitor cells and inhibit enhanced angiogenesis. Furthermore, it is capable of ex vivo expanding normal stem and progenitor cells. The invention also encompasses pharmaceutical compositions that may inhibit enhanced angiogenesis, induce tumor remission, maintain tumor remission, and expand hematopoietic normal stem and progenitor bone marrow transplants.
Career Highlights
Throughout his career, Rachmilewitz has worked with Hadasit Medical Research Services and Development Company, as well as Hadasit Medical Research Services and Development Ltd. His work in these organizations has allowed him to focus on innovative medical research and development.
Collaborations
Rachmilewitz has collaborated with notable colleagues such as Tony Peled and Eitan Fibach. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eliezer A Rachmilewitz is a distinguished inventor whose work in serum-derived compositions has the potential to revolutionize medical treatments. His contributions to the field of medical research are noteworthy and continue to inspire innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile